Drugs / MTX
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT03082144 Comparator | Feb 2017 → May 2018 | neoplastic meningitis | The First Hospital of Jilin University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MTX | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03082144 ↗ |
| Route | Intrathecal | “Intrathecal chemotherapy: MTX 15 mg, plus dexamethasone 5 mg, via lumbar puncture” NCT03082144 ↗ |